Reproductive toxicity following in utero and lactational exposure to a human-relevant phthalate mixture in rats

This rodent (Wistar rats) study examined reproductive effects of in utero/lactational exposure to a mixture of six antiandrogenic phthalates (PMix): diisobutyl phthalate (DiBP), di-n-butyl phthalate (DnBP), diisopentyl phthalate (DiPeP), butylbenzyl phthalate (BBzP), di-2-ethylhexyl phthalate (DEHP), and diisononyl phthalate (DiNP). The PMix was defined based on exposure data from pregnant women in Brazil. Experimental groups were established by extrapolating the estimated human dose to rats (0.1 mg/kg/day), followed by up to three additional doses corresponding to 5, 1000 and 5000 times the starting rat dose: 0 (control), 0.1, 0.5, 100 and 500 mg/kg/day. The fetal experiment assessed gestational exposure effects on fetal gonads, while the postnatal experiment evaluated reproductive parameters in males and females after in utero and lactational exposure. Prenatal exposure decreased fetal testicular testosterone production at 0.5 and 500 mg/kg/day. PMix 500 also reduced mRNA expression of steroidogenesis-related genes, upregulated transcript expression of the retinoic acid-degrading enzyme Cyp26b1, and increased multinucleated gonocytes incidence in fetal testes. Postnatal assessment revealed antiandrogenic effects at the highest dose, including reduced anogenital distance, nipple retention, and decreased weight of reproductive organs. Early puberty onset (preputial separation) was observed at the lowest dose in males. In contrast, females did not show significant changes in fetal and adult endpoints. Overall, the PMix recapitulated early and late male rat phthalate syndrome phenotypes at the highest dose, but also induced some subtle changes at lower doses, which warrant confirmation and mechanistic assessments. Our data support the use of epidemiologically defined mixtures for exposure risk assessments over traditional toxicological approaches.